PATHOLOGY & ONCOLOGY RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2024-05-23 shiny_hni 来自北京

审稿速度:6.0 | 投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。

69 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-09-21 ms5000001091496643 来自浙江省

审稿速度:6.0 | 投稿命中率:50.0
经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投

0 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2023-07-07 ms3000000754910981 来自河北省

偏重的研究方向：肿瘤
经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…

128 6 举报

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-07-23 ms1000001460451352

22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受

114 4 举报

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-11-26 ms5000001226862916 来自北京

想请问这个杂志多久分配编辑啊

105 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-02-24 ms4000001231050039

接收纯生信吗？

120 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-03-24 liumin1987

需要交版面费吗？

148 3 举报

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2022-01-28 火山vocdophin

我的为什么不能点击投稿啊

120 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？

137 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2206206, encodeId=b4d62206206d6, content=审稿速度:6.0 | 投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：前后投了两个病例分析，一个接收，一个拒绝。审稿时间比较长。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJXmeEY2DEia1ojibeyQFTH9fjVGelKKrGUaZ9ia5RQIhdE8EibFIf42cVI9cdXicmG5f5ujIaRW1ROnXw/132, createdBy=5dc42247864, createdName=shiny_hni, createdTime=Thu May 23 15:42:16 CST 2024, time=2024-05-23, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2158959, encodeId=7735215895907, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：五月多投稿，八月返回小修，两个审稿人均同意发表，小修后无理由拒稿，慎投, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09825505976, createdName=ms5000001091496643, createdTime=Thu Sep 21 19:21:11 CST 2023, time=2023-09-21, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2146756, encodeId=3c222146e56d6, content=偏重的研究方向：肿瘤 经验分享：6月21日投稿，26日重新提交，到现在7月7日还是初审阶段，未分配编辑…, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=128, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=216f8181041, createdName=ms3000000754910981, createdTime=Fri Jul 07 08:13:13 CST 2023, time=2023-07-07, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=1234290, encodeId=423c1234290be, content=22年3月中旬初投，被编辑退回来修改文章撰写，4月上旬重投，外审大概2周，5月初给返修，润色花了大概2周时间，5月底接受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=badb5680040, createdName=ms1000001460451352, createdTime=Sat Jul 23 19:55:27 CST 2022, time=2022-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102761, encodeId=d6932102e6141, content=想请问这个杂志多久分配编辑啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd535555461, createdName=ms5000001226862916, createdTime=Sat Nov 26 15:54:07 CST 2022, time=2022-11-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1197007, encodeId=40a1119e00788, content=接收纯生信吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=313c6485225, createdName=ms4000001231050039, createdTime=Thu Feb 24 21:18:29 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950694, encodeId=6c2a95069413, content=需要交版面费吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/07/16/3b24606172648eea459125cb74754afe.jpg, createdBy=6c022216608, createdName=liumin1987, createdTime=Wed Mar 24 11:38:53 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1188794, encodeId=d9301188e94f3, content=我的为什么不能点击投稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d161762963, createdName=火山vocdophin, createdTime=Fri Jan 28 11:50:50 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096540, encodeId=2fd8109654061, content=评审要求我补充实验，可我的样品已经用完了/实验已经结束了，直接说我样本用完了会被拒稿么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=137, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096539, encodeId=6a5b109653973, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=)]

2021-12-29 Gym璨烨

回复评审的意见和期刊编辑的意见有什么不同？

119 1 举报

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务